Skip to main content

Peer Review reports

From: A network-based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancer

Original Submission
16 Oct 2023 Submitted Original manuscript
5 Nov 2023 Reviewed Reviewer Report
24 Nov 2023 Reviewed Reviewer Report - Sushil Kumar Shakyawar
6 Dec 2023 Author responded Author comments - Regan Odongo
12 Dec 2023 Author responded Author comments - Regan Odongo
Resubmission - Version 2
6 Dec 2023 Submitted Manuscript version 2
26 Dec 2023 Reviewed Reviewer Report - Sushil Kumar Shakyawar
5 Jan 2024 Reviewed Reviewer Report
11 Jan 2024 Author responded Author comments - Regan Odongo
Resubmission - Version 3
11 Jan 2024 Submitted Manuscript version 3
7 Feb 2024 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
12 Feb 2024 Editorially accepted
21 Feb 2024 Article published 10.1186/s13040-024-00357-1

You can find further information about peer review here.

Back to article page